2 Patents
- US116334282023Targeting of SRC-3 in Immune Cells as an Immunomodulatory Therapeutic for the Treatment of Cancer
Baylor College Of Medicine
0 cites - US116334292023Targeting of SRC-3 in Immune Cells as an Immunomodulatory Therapeutic for the Treatment of Cancer
Baylor College Of Medicine
0 cites